Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata)

Peptides

Volumn 27, Issue 9, 2006, Pages 2214-2223

  Silva, Maria A de Souza ^a   Mello Jr , Eldon L ^b   Müller, Christian P ^a   Jocham, Gerhard ^a   Maior, Rafael S ^b   Huston, Joseph P ^a   Tomaz, Carlos ^b   Barros, Marilia ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Behavior; Cocaine; Marmoset; Senktide; Sensitivity; Tachykinin NK3 receptor

Indexed keywords

COCAINE; SENKTIDE; DRUG DERIVATIVE; NEUROKININ 3 RECEPTOR; PEPTIDE FRAGMENT; SUBSTANCE P; TACHYKININ;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CALLITHRIX PENICILLATA; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; LOCOMOTION; MALE; MARMOSET; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; SELF CARE; ANIMAL; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; METABOLISM; MOTOR ACTIVITY; RAT;

ANIMALIA; CALLITHRIX PENICILLATA; MARMOSETS; PRIMATES;

ANIMALS; BEHAVIOR, ANIMAL; CALLITHRIX; COCAINE; DRUG INTERACTIONS; FEMALE; MALE; MAZE LEARNING; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; RATS; RECEPTORS, NEUROKININ-3; SUBSTANCE P; TACHYKININS;

EID: 33746897012     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.03.005     Document Type: Article

References (50)

1. Adams D.H., Hanson G.R., and Keefe K.A. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102 (2001) 843-851
2. Alburges M.E., Ramos B.P., Bush L., and Hanson G.R. Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments. Eur J Pharmacol 390 (2000) 119-126
3. Arroyo M., Baker W.A., and Everitt B.J. Cocaine self-administration in rats differentially alters mRNA levels of the monoamine transporters and striatal neuropeptides. Mol Brain Res 83 (2000) 107-120
4. Barnes J.M., Barnes N.M., Costall B., Cox A.J., Domeney A.M., Kelly M.E., et al. Neurochemical consequences following injection of the substance-P analog, DiMe-C7, into the rat ventral tegmental area. Pharmacol Biochem Behav 37 (1990) 839-841
5. Barros M., and Tomaz C. Non-human primate models for investigating fear and anxiety. Neurosci Biobehav Rev 26 (2002) 187-201
6. Barros M., Boere V., Mello E.L., and Tomaz C. Reactions to potential predators in captive-born marmosets (Callithrix penicillata). Int J Primatol 23 (2002) 443-454
7. Barros M., de Souza Silva M.A., Huston J.P., and Tomaz C. Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata). Peptides 23 (2002) 967-973
8. Barros M., Mello E.L., Maior R.S., Müller C.P., de Souza Silva M.A., Carey R.J., et al. Anxiolytic-like effects of the selective 5-HT1A receptor antagonist WAY 100635 in non-human primates. Eur J Pharmacol 482 (2003) 197-203
9. Barros M., Alencar C., and Tomaz C. Differences in aerial and terrestrial visual scanning in captive black tufted-ear marmosets (Callithrix penicillata) exposed to a novel environment. Folia Primatol 75 (2004) 85-92
10. Barros M., de Souza Silva M.A., Huston J.P., and Tomaz C. Multibehavioral analysis of fear and anxiety before, during, and after experimentally induced predatory stress in Callithrix penicillata. Pharmacol Biochem Behav 78 (2004) 357-367
11. Caine N.G. Visual scanning by tamarins-a description of the behavior and tests of 2 derived hypotheses. Folia Primatol 43 (1984) 59-67
12. Caine N.G. Cutting costs in response to predatory threat by Geoffroy's marmosets (Callithrix geoffroyi). Am J Primatol 46 (1998) 187-196
13. Ciccocioppo R., Panocka I., Pompei P., DeCaro G., and Massi M. Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats. Brain Res Bull 33 (1994) 71-77
14. Ciccocioppo R., Panocka I., Pompei P., Polidori C., DeCaro G., and Massi M. Subcutaneous injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats. Peptides 16 (1995) 533-537
15. Ciccocioppo R., Panocka I., Polidori C., DeCaro G., Regoli D., and Massi M. Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats. Peptides 18 (1997) 1349-1355
16. Ciccocioppo R., Panocka I., Polidori C., Froldi R., Angeletti S., and Massi M. Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide. Pharmacol Biochem Behav 61 (1998) 459-464
17. Conde C.A., Costa V., and Tomaz C. PROSTCOM: Un conjunto de programas para registro y procesamiento de datos comportamentales en investigaciones de fisiologia y farmacologia. Biotemas 13 (2000) 357-367
18. Davidson C., Lee T.H., and Ellinwood E.H. NKI receptor antagonist WIN51708 reduces sensitization after chronic cocaine. Eur J Pharmacol 499 (2004) 355-356
19. De Souza Silva MA, Mello Jr. EL, Müller CP, Jocham G, Souto Maior R, Huston JP, Tomaz C, Barros M. The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys. Eur J Pharmacol, in press.
20. Eison A.S., Eison M.S., and Iversen S.D. The behavioral-effects of a novel substance-P analog following infusion into the ventral tegmental area or substantia nigra of rat-brain. Brain Res 238 (1982) 137-152
21. Emonds Alt X., Bichon D., Ducoux J.P., Heaulme M., Miloux B., Poncelet M., et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci 56 (1995) L27-L32
22. Ferrari S.F., and Ferrari M.A.L. Predator avoidance-behavior in the buffy-headed marmoset, Callithrix-Flaviceps. Primates 31 (1990) 323-338
23. Hall M.E., Grantham P., Limoli J., and Stewart J.M. Effects of substance-P and neurokinin-A (substance-K) on motor behavior-unique effect of substance-P attributable to its amino-terminal sequence. Brain Res 420 (1987) 82-94
24. Hardie S.M., and BuchananSmith H.M. Vigilance in single- and mixed-species groups of tamarins (Saguinus labiatus and Saguinus fuscicollis). Int J Primatol 18 (1997) 217-234
25. Hökfelt T., Pernow B., and Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med 249 (2001) 27-40
26. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., and Gerfen C.R. Cocaine self-administration differentially alters messenger-RNA expression of striatal peptides. Mol Brain Res 13 (1992) 165-170
27. Huston J.P., Hasenöhrl R.U., Boix F., Gerhardt P., and Schwarting R.K.W. Sequence-specific effects of neurokinin substance-P on memory, reinforcement, and brain dopamine activity. Psychopharmacology 112 (1993) 147-162
28. Jocham G, Lezoch K, Müller CP, Kart-Teke E, Huston JP, de Souza Silva MA. Neurokinin3 receptor antagonism attenuates cocaine's behavioral activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core. submitted for publication.
29. Johanson C.E., and Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol Rev 41 (1989) 3-52
30. Johansson B., Lindstrom K., and Fredholm B.B. Differences in the regional and cellular-localization of c-Fos messenger-RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59 (1994) 837-849
31. Kelley A.E., Stinus L., and Iversen S.D. Behavioral activation induced in the rat by substance-P infusion into ventral tegmental area-implication of dopaminergic A10 neurons. Neurosci Lett 11 (1979) 335-339
32. Koenig A. Visual scanning by common marmosets (Callithrix jacchus): functional aspects and the special role of adult males. Primates 39 (1998) 85-90
33. Kraft M., Ahluwahlia S., and Angulo J.A. Neurokinin-1 receptor antagonists block acute cocaine-induced horizontal locomotion. Ann NY Acad Sci 937 (2001) 132-139
34. Loonam T.M., Noailles P.A.H., Yu J., Zhu J.P.Q., and Angulo J.A. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Life Sci 73 (2003) 727-739
35. Massi M., Panocka I., and de Caro G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 21 (2000) 1597-1609
36. Mathieu-Kia A.M., and Besson M.J. Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Mol Brain Res 54 (1998) 141-151
37. Mello E.L., Maior R.S., Carey R.J., Huston J.P., Tomaz C., and Müller C.P. Serotonin(1A)-receptor antagonism blocks psychostimulant properties of diethylpropion in marmosets (Callithrix peniccillata). Eur J Pharmacol 511 (2005) 43-52
38. Müller C.P., de Souza-Silva M.A., DePalma G., Tomaz C., Carey R.J., and Huston J.P. The selective serotonin1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res 134 (2002) 337-346
39. Nguyen-Le X.K., Nguyen Q.T., Gobeil F., Pheng L.H., Emonds-Alt X., Breliere J.C., et al. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor. Pharmacology 52 (1996) 283-291
40. Perfumi M., Polidori C., Pompei P.L., DeCaro G., and Massi M. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats. Pharmacol Biochem Behav 38 (1991) 881-887
41. Placenza F.M., Fletcher P.J., Rotzinger S., and Vaccarino F.J. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats. Psychopharmacology 177 (2004) 111-120
42. Placenza F.M., Vaccarino F.J., Fletcher P.J., and Erb S. Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behavior. Neurosci Lett 390 (2005) 42-47
43. Regoli D., Boudon A., and Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46 (1994) 551-599
44. Ripley T.L., Gadd C.A., De Felipe C., Hunt S.P., and Stephens D.N. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43 (2002) 1258-1268
45. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol Rev 54 (2002) 285-322
46. Stevenson M.F., and Poole T.B. Ethnogram of common marmoset (Calithrix-Jacchus-Jacchus)-general behavioral repertoire. Animal Behav 24 (1976) 428-451
47. Stevenson M.F., and Rylands A.B. The marmosets, genus Callithrix. In: Mittermeier R.A., Rylands A.B., Coimbra-Filho A., and Fonseca G.A.B. (Eds). Ecology and behavior of neotropical primates (1988) 131-222
48. Stoessl A.J., Dourish C.T., and Iversen S.D. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behavior following central or peripheral administration in mice and rats. Br J Pharmacol 94 (1988) 285-287
49. Stoessl A.J., Dourish C.T., and Iversen S.D. Pharmacological characterization of the behavioral syndrome induced by the NK-3 tachykinin agonist senktide in rodents-evidence for mediation by endogenous 5-HT. Brain Res 517 (1990) 111-116
50. Ukai M., Mori E., and Kameyama T. Effects of centrally administered neuropeptides on discriminative stimulus properties of cocaine in the rat. Pharmacol Biochem Behav 51 (1995) 705-708